Skip to main content
Top
Published in: Indian Journal of Gastroenterology 3/2018

01-05-2018 | Original Article

Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet

Authors: Ashish Joshi, Sushil Falodia, Naveen Kumar, Pawan Gupta, P. C. Khatri

Published in: Indian Journal of Gastroenterology | Issue 3/2018

Login to get access

Abstract

Background

Liver involvement in celiac disease (CD) is classified into autoimmune and cryptogenic. The association between CD and autoimmune liver diseases like autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis is well-established; however, the data on patients with cryptogenic cirrhosis, particularly from India, are scanty. So we did this study to find the prevalence of CD in patients with cryptogenic cirrhosis.

Methods

This was a prospective observational study, involving children of less than 18 years old attending Pediatric and Gastroenterology clinic with a diagnosis of cryptogenic cirrhosis. The patients were evaluated for CD and divided into two groups: chronic liver disease (CLD) with CD, and CLD without CD. Both the groups were followed up for 6 months. CLD with CD group was treated with gluten-free-diet (GFD) and CLD without CD group was followed up without any specific intervention except standard care of CLD.

Results

Out of 84 patients, 11 (13.1%) were diagnosed as CLD with CD. There was an improvement in hemoglobin levels, liver function tests, and Child-Pugh score after initiation of GFD in CLD with CD group.

Conclusion

The prevalence of CD in cryptogenic cirrhosis was 13.1%. Screening for CD is recommended for cryptogenic cirrhosis. Hepatic functions improve with a GFD in CD patients with cirrhosis.
Literature
2.
go back to reference Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.CrossRefPubMed Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.CrossRefPubMed
3.
go back to reference Sood A, Midha V, Sood N, et al. Prevalence of celiac disease among school going children in Punjab, North India. J Gastroenterol Hepatol. 2006;21:1622–5.CrossRefPubMed Sood A, Midha V, Sood N, et al. Prevalence of celiac disease among school going children in Punjab, North India. J Gastroenterol Hepatol. 2006;21:1622–5.CrossRefPubMed
4.
go back to reference Hu WT, Murray JA, Greenway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–6.CrossRefPubMed Hu WT, Murray JA, Greenway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–6.CrossRefPubMed
5.
6.
go back to reference Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.CrossRefPubMed Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.CrossRefPubMed
7.
go back to reference Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.CrossRefPubMed Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.CrossRefPubMed
8.
9.
go back to reference De Franceschi L, Volta U, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.CrossRefPubMed De Franceschi L, Volta U, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.CrossRefPubMed
10.
go back to reference Mounajjed T, Oxentenko A, Shmidt E, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol. 2011;136:128–37.CrossRefPubMed Mounajjed T, Oxentenko A, Shmidt E, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol. 2011;136:128–37.CrossRefPubMed
11.
go back to reference Philips AC, Sahney A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4:186–95. Philips AC, Sahney A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4:186–95.
13.
go back to reference Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut. 2013;62:43–52.CrossRefPubMed Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut. 2013;62:43–52.CrossRefPubMed
14.
go back to reference Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, Eds. Harrison’s Principles of Internal Medicine. 19th ed. New York: Mc Graw Hill;2015:1989–95. Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, Eds. Harrison’s Principles of Internal Medicine. 19th ed. New York: Mc Graw Hill;2015:1989–95.
15.
go back to reference Maiwall R, Goel A, Pulimood AB, et al. Investigation into celiac disease in Indian patients with portal hypertension. Indian J Gastroenterol. 2014;33:517–23.CrossRefPubMed Maiwall R, Goel A, Pulimood AB, et al. Investigation into celiac disease in Indian patients with portal hypertension. Indian J Gastroenterol. 2014;33:517–23.CrossRefPubMed
16.
go back to reference Lindgren S, Sjoberg K, Eriksson S. Unsuspected celiac disease in chronic cryptogenic liver disease. Scand J Gastroenterol. 1994;29:661–4.CrossRefPubMed Lindgren S, Sjoberg K, Eriksson S. Unsuspected celiac disease in chronic cryptogenic liver disease. Scand J Gastroenterol. 1994;29:661–4.CrossRefPubMed
17.
go back to reference Stevens FM, McLoughlin RM. Celiac disease is potentially treatable cause of liver failure. Eur J Gastroenterol Hepatol. 2005;17:1015–7.CrossRefPubMed Stevens FM, McLoughlin RM. Celiac disease is potentially treatable cause of liver failure. Eur J Gastroenterol Hepatol. 2005;17:1015–7.CrossRefPubMed
18.
go back to reference Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881–8.CrossRefPubMed Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881–8.CrossRefPubMed
19.
go back to reference Korponay-Szabó IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.CrossRefPubMedPubMedCentral Korponay-Szabó IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.CrossRefPubMedPubMedCentral
21.
go back to reference Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 1999;29:654–7.CrossRefPubMed Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 1999;29:654–7.CrossRefPubMed
22.
go back to reference Bonamico M, Pitzalis G, Culasso F, et al. Hepatic damage during celiac disease in childhood. Minerva Pediatr. 1986;38:959–63.PubMed Bonamico M, Pitzalis G, Culasso F, et al. Hepatic damage during celiac disease in childhood. Minerva Pediatr. 1986;38:959–63.PubMed
23.
go back to reference Volta U, De Franceschi L, Lari F, et al. Celiac disease hidden by cryptogenic hypertransaminasemia. Lancet. 1998;352:26–9.CrossRefPubMed Volta U, De Franceschi L, Lari F, et al. Celiac disease hidden by cryptogenic hypertransaminasemia. Lancet. 1998;352:26–9.CrossRefPubMed
24.
go back to reference Ozkan M, Trandafir L, Bozomitu L, et al. Liver involvement in celiac disease in children. Rev Med Chir Soc Med Nat Iasi. 2011;115:1030–4.PubMed Ozkan M, Trandafir L, Bozomitu L, et al. Liver involvement in celiac disease in children. Rev Med Chir Soc Med Nat Iasi. 2011;115:1030–4.PubMed
25.
go back to reference Singh P, Agnihotri A, Jindal G, et al. Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol. 2013;32:404–8.CrossRefPubMed Singh P, Agnihotri A, Jindal G, et al. Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol. 2013;32:404–8.CrossRefPubMed
26.
go back to reference Das P, Makharia GK. Gut-liver axis and disease infidelity: a subject worth exploring. Indian J Gastroenterol. 2014;33:503–6.CrossRefPubMed Das P, Makharia GK. Gut-liver axis and disease infidelity: a subject worth exploring. Indian J Gastroenterol. 2014;33:503–6.CrossRefPubMed
27.
go back to reference Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract. 2012;2012:85WE9697.CrossRef Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract. 2012;2012:85WE9697.CrossRef
Metadata
Title
Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet
Authors
Ashish Joshi
Sushil Falodia
Naveen Kumar
Pawan Gupta
P. C. Khatri
Publication date
01-05-2018
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 3/2018
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-018-0857-6

Other articles of this Issue 3/2018

Indian Journal of Gastroenterology 3/2018 Go to the issue